Bimekizumab for treating ankylosing spondylitis [TSID10334]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Sarilumab for treating polyarticular or oligoarticular juvenile idiopathic arthritis in people 2 to 17 years [TSID10237]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Deucravacitinib for treating active psoriatic arthritis [TSID11981]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC